Risk factors for spastic cerebral palsy: a retrospective cross-sectional study and literature review

Xing Wang1, Xiao-Gang Du1, Siew Hoon Teh2

  • 1Famous TCM Expert Heritage Studio, Xi'an Encephalopathy Hospital Affiliated to Shaanxi University of Chinese Medicine, Xi'an, Shaanxi, China.

PubMed

Insights

Spastic cerebral palsy (CP) risk factors include neonatal issues like asphyxia and prematurity. Improved prenatal care and reduced maternal exposure to toxins are key for prevention.

Area of Science:

  • Pediatrics
  • Neurology
  • Public Health

Background:

  • Cerebral Palsy (CP) is a common lifelong neurodevelopmental disorder.
  • Spastic CP accounts for 70% of all CP cases, primarily affecting young children.
  • Understanding spastic CP risk factors is crucial for developing effective clinical strategies.

Purpose of the Study:

  • To investigate the risk factors associated with spastic Cerebral Palsy (CP).
  • To analyze demographic and clinical data of spastic CP patients.
  • To review existing literature on spastic CP etiology to inform prevention and management.

Main Methods:

  • Retrospective cross-sectional analysis of 231 spastic CP patients (aged 4-14) records.
  • Data collection from Xi'an Encephalopathy Hospital (October 2021-September 2022).
  • Statistical analysis of demographic data and risk factors, supplemented by a literature review.

Main Results:

  • Key risk factors identified include neonatal asphyxia (63.20%), premature birth (49.78%), and low birth weight (49.35%).
  • Other significant factors: maternal prenatal illnesses, cesarean delivery (32.90% in preterm), and environmental pollutants.
  • Patient demographics: 55.41% male, 52.84% urban residents; peak age at diagnosis around 4 years old.

Conclusions:

  • Findings highlight the importance of addressing neonatal complications and prenatal factors.
  • Recommendations include enhanced prenatal care, infection control, and minimizing maternal exposure to toxins, alcohol, and medications.
  • Early, personalized interventions are supported for at-risk infants to mitigate spastic CP development.
Abstract